BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit

Impact · against what's priced in

BBNX faces significant new legal and regulatory risk following a class action lawsuit alleging the company concealed serious device injuries and systemic quality failures. PZZA is unaffected as the news pertains to Beta Bionics, despite the prior analysis erroneously linking the two.

PZZA+0.00

Doesn't touch the price's assumptions

The price assumes

The ongoing securities fraud litigation regarding misleading statements about the turnaround.